Emotionally abused children may face accelerated cellular aging as adults

21. November 2009 00:51

Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University. [More]

7e88910b-c8a9-48cc-80b5-9204181b721a|0|.0

Posted in: Child Health News | Medical Science News

Tags: Cancer, Cardiovascular Disease, DNA, Hospital, Mental Health, Psychiatry, Stress, Telomere, Trauma

FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder

21. November 2009 00:32

Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating that Geodon is an effective and generally well-tolerated adjunctive treatment for long-term symptom control in patients with bipolar disorder. [More]

e509995b-1b4e-4e92-b105-966405d5524b|1|5.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Antipsychotic, Arrhythmia, Bipolar Disorder, Blood Pressure, Dementia, Diabetes, Hyperglycemia, Mental Health, Pfizer, Pharmacology, Psychiatry, Psychosis, Schizophrenia

Intensive refresher course in pediatrics for physicians preparing for certification examination

19. November 2009 06:55

Research and Markets (http://www.researchandmarkets.com/research/d3e55b/pediatric_board_re) has announced the addition of the "Pediatric Board Review" report to their offering. [More]

d4ec9abc-91de-438c-89da-9ba0d7241de0|0|.0

Posted in: Child Health News

Tags: Allergy, Autism, Biochemistry, Cardiology, Dermatology, Education, Endocrinology, Gastroenterology, Genetics, Hematology, Hospital, Immunology, Learning Disability, Metabolism, Nephrology, Neurology, Nutrition, Obstetrics, Oncology, Ophthalmology, Orthopedic, Pediatrics, Psychiatry, Radiology, Rheumatology, Sports Medicine

New report finds positive association between phthalate exposure and ADHD symptoms

19. November 2009 04:44

Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Studies to date on phthalates have been inconsistent, with some linking exposure to these chemicals to hormone disruptions, birth defects, asthma, and reproductive problems, while others have found no significant association between exposure and adverse effects. [More]

b57e5386-e64a-4213-b33d-a5d695037bbe|0|.0

Posted in: Medical Condition News

Tags: Asthma, Phthalates, Psychiatry

Patients with recent-onset schizophrenia have raised levels of inflammatory substances

18. November 2009 11:24

Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system. [More]

2e617195-486b-40f9-a683-279e16f7f60d|0|.0

Posted in: Medical Research News | Medical Condition News

Tags: Brain, Dopamine, Education, Immunotherapy, Pharmacology, Physiology, Psychiatry, Schizophrenia

A fact-based media briefing on bipolar disorder in Nova Scotia

18. November 2009 06:57

An estimated 26,000 Nova Scotians live with bipolar disorder. Often stigmatized in popular culture, the experience of bipolar disorder varies from one person to the next and almost always has a drastic impact on how individuals think, behave and function. [More]

34a183a8-e2e9-4983-a808-d4f61c62a6bb|1|5.0

Posted in: Medical Condition News

Tags: Bipolar Disorder, Depression, Education, Mental Health, Psychiatry, Seniors

Depression is as much of a risk factor for mortality as smoking, says new study

17. November 2009 23:51

A study by researchers at the University of Bergen, Norway, and the Institute of Psychiatry (IoP) at King's College London has found that depression is as much of a risk factor for mortality as smoking. [More]

648d67f7-39a1-43b4-89c4-c9b12889dad8|0|.0

Posted in: Medical Condition News

Tags: Anxiety, Blood Pressure, Cholesterol, Dentistry, Depression, Diet, DNA, Education, Exercise, Hospital, Mental Health, Psychiatry, Smoking, Stress

Shire publishes new study results on INTUNIV Extended-Release Tablets

17. November 2009 04:21

Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone. [More]

f1905e57-99d9-420f-9a01-cfb46c853f5f|0|.0

Posted in: Child Health News | Pharmaceutical News

Tags: Abdominal Pain, Blood Pressure, CDC, Constipation, Headache, Hypersensitivity, Insomnia, Psychiatry, Psychopharmacology

Results of Phase III clinical trials of flibanserin for treatment of HSDD in pre-menopausal women released

16. November 2009 23:15

Data from pivotal Phase III clinical trials demonstrate that flibanserin 100mg increased the number of satisfying sexual events (SSE) and sexual desire (the co-primary endpoints) while decreasing the distress associated with Hypoactive Sexual Desire Disorder (HSDD). [More]

fe6591e4-7cff-4f7c-8588-11b60413a85a|0|.0

Posted in: Drug Trial News | Women's Health News

Tags: Anxiety, Contraception, Insomnia, Nausea, Psychiatry, Sexual Dysfunction

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

16. November 2009 08:49

Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002). [More]

7c593e0c-d5f3-4682-acec-c6479a87a418|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Alcohol Dependence, Analgesia, Biotechnology, Depression, Diabetes, Dyspnea, Headache, Heroin, Hypersensitivity, Insomnia, Nausea, Nervous System, New Drug Application, Opioid Drug, Opioids, Pneumonia, Psychiatry, Schizophrenia, Vivitrol, Vomiting

Findings from post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse announced

16. November 2009 05:57

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse-. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years. [More]

61ba286d-5b3b-4047-95a2-27f2235034f8|0|.0

Posted in: Child Health News | Drug Trial News

Tags: Abdominal Pain, Arteriosclerosis, Bipolar Disorder, Blood Pressure, Cardiovascular Disease, CDC, Depression, Drug Abuse, Glaucoma, Headache, Hypersensitivity, Hyperthyroidism, Insomnia, Nausea, Psychiatry, Psychosis, Stroke, Vomiting

Chronic pain patients with depression three times more likely to receive opioid medications

16. November 2009 03:59

Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research. [More]

e13e4d3e-7359-43c3-a089-d181eba71734|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Brain, Depression, Hospital, Opioids, Psychiatry, Vicodin

NIDA awards $17 million to University of California to establish TMARC

16. November 2009 03:34

Igor Grant, MD, professor of psychiatry at the University of California, San Diego School of Medicine, and colleagues have been awarded a $17 million grant from the National Institute on Drug Abuse to establish the Translational Methamphetamine AIDS Research Center (TMARC) at UC San Diego. Grant is director of the HIV Neurobehavioral Research Center (HNRC), a clinical research center designated and funded by the National Institute of Mental Health. [More]

e42fb698-fead-4826-bcbb-88ec632757e6|0|.0

Posted in: Disease/Infection News

Tags: Brain, Drug Abuse, Mental Health, Nervous System, Psychiatry, Virus

Study confirms that people with severe mental disorders more at risk of dying from heart disease

13. November 2009 10:23

A large new study confirms that people with severe mental disorders — such as schizophrenia or other psychotic disorders — are 25 percent to 40 percent more prone to die from heart disease than people without mental illness are. [More]

0231b490-9ebf-45e9-bd3c-28971edb532c|1|4.0

Posted in: Medical Condition News

Tags: Antipsychotic, Cardiovascular Disease, CDC, Dementia, Diabetes, Exercise, Health Reform, Hospital, Psychiatry, Psychosis, Schizophrenia, Smoking

M3 USA collaborates with Bristol-Myers Squibb to launch its next-generation eLearning and eMarketing solution

13. November 2009 09:28

M3 USA, together with Bristol-Myers Squibb (NYSE: BMY), is launching a pilot program to oncologists using M3’s next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology. [More]

3063b676-7591-4027-9b50-d4c0d9d3841b|0|.0

Posted in: Device / Technology News

Tags: Cardiology, Oncology, Psychiatry

Free!

Recent Comments

Twitter

Information

Psychiatry News and Research

Emotionally abused children may face accelerated cellular aging as adults

FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder

Intensive refresher course in pediatrics for physicians preparing for certification examination

New report finds positive association between phthalate exposure and ADHD symptoms

Patients with recent-onset schizophrenia have raised levels of inflammatory substances

A fact-based media briefing on bipolar disorder in Nova Scotia

Depression is as much of a risk factor for mortality as smoking, says new study

Shire publishes new study results on INTUNIV Extended-Release Tablets

Results of Phase III clinical trials of flibanserin for treatment of HSDD in pre-menopausal women released

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Findings from post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse announced

Chronic pain patients with depression three times more likely to receive opioid medications

NIDA awards $17 million to University of California to establish TMARC

Study confirms that people with severe mental disorders more at risk of dying from heart disease

M3 USA collaborates with Bristol-Myers Squibb to launch its next-generation eLearning and eMarketing solution

Recent Articles

Free!

Recent Comments

Twitter

Information

Psychiatry News and Research

Medical News Cloud

Recent Articles